4.79
price up icon9.61%   0.42
after-market After Hours: 4.79
loading
Jaguar Health Inc stock is traded at $4.79, with a volume of 36,533. It is up +9.61% in the last 24 hours and down -66.79% over the past month.
See More
Previous Close:
$4.37
Open:
$4.12
24h Volume:
36,533
Relative Volume:
1.52
Market Cap:
$2.87M
Revenue:
$10.48M
Net Income/Loss:
$-37.74M
P/E Ratio:
-0.296
EPS:
-16.1846
Net Cash Flow:
$-29.03M
1W Performance:
+0.63%
1M Performance:
-66.79%
6M Performance:
-85.15%
1Y Performance:
-96.20%
1-Day Range:
Value
$4.02
$4.79
1-Week Range:
Value
$4.02
$4.9699
52-Week Range:
Value
$4.02
$540.00

Jaguar Health Inc Stock (JAGX) Company Profile

Name
Name
Jaguar Health Inc
Name
Phone
415-371-8300
Name
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Name
Employee
0
Name
Twitter
@Jaguar_Health
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
JAGX's Discussions on Twitter

Compare JAGX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
JAGX
Jaguar Health Inc
4.79 2.87M 10.48M -37.74M -29.03M -16.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.56 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.78 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
550.00 33.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.95 30.15B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
220.54 25.69B 3.81B -644.79M -669.77M -6.24

Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-07-21 Initiated Cantor Fitzgerald Overweight
Jul-11-17 Initiated Rodman & Renshaw Buy

Jaguar Health Inc Stock (JAGX) Latest News

pulisher
Apr 06, 2025

Jaguar Health's Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer - ACCESS Newswire

Apr 06, 2025
pulisher
Apr 04, 2025

Jaguar Animal Health Secures $3.448M in Private Placement - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials - ACCESS Newswire

Apr 04, 2025
pulisher
Apr 04, 2025

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ACCESS Newswire

Apr 04, 2025
pulisher
Apr 04, 2025

Jaguar Health Expands Workforce: New Stock Grants Signal Growth Strategy - Stock Titan

Apr 04, 2025
pulisher
Apr 04, 2025

Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4) - ACCESS Newswire

Apr 04, 2025
pulisher
Apr 03, 2025

Jaguar Health outlines key Q2 2025 catalysts for crofelemer programs - MSN

Apr 03, 2025
pulisher
Apr 03, 2025

Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 02, 2025

Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 01, 2025

Jaguar Health completes $3.4 million private placement By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health completes $3.4 million private placement - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health CEO Leads $3.4M Strategic Investment Ahead of Key 2025 Catalysts - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

Jaguar Health Advances Plant-Based Pharmaceuticals - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Jaguar Health’s Earnings Call: Growth Amid Challenges - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

JAGX stock plunges to 52-week low, touches $4.9 amid steep decline - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Jaguar Health sees revenue growth in Q4 2024 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Jaguar Health, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 28, 2025

StockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - Weatherford Democrat

Mar 28, 2025
pulisher
Mar 27, 2025

Jaguar Health at Emerging Growth Virtual Conference: Strategic Catalysts Ahead - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Jaguar Health CEO, board members and investors invest in $3.448M bridge financing - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 27, 2025

Mytesi Shows Promising Results in Breast Cancer: FDA to Review Game-Changing Phase 3 Data - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Sector Update: Health Care - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health secures $3.448 million in convertible notes - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts - Corsicana Daily Sun

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health Executives Invest in $3.5 Million Bridge Financing; Shares Fall - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Jaguar Health Management Backs Company with Personal Investment in $3.4M Financing Deal - Stock Titan

Mar 26, 2025
pulisher
Mar 24, 2025

Upcoming Stock Splits This Week (March 24 to March 28) – Stay Invested - The Globe and Mail

Mar 24, 2025
pulisher
Mar 21, 2025

JAGX stock touches 52-week low at $0.21 amid sharp annual decline - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

JAGX stock touches 52-week low at $0.21 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 20, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Jaguar Health (NASDAQ:JAGX) Now Covered by StockNews.com - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Jaguar Health initiates reverse stock split to meet Nasdaq standards By Investing.com - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health falls as it announces reverse stock split - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health to Implement 1-for-25 Reverse Stock Split -March 18, 2025 at 09:05 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Animal Health Announces Reverse Stock Split - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health initiates reverse stock split to meet Nasdaq standards - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health, Inc. Announces Reverse Stock Split - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Jaguar Health's Major 1:25 Reverse Split: Critical Move for Nasdaq Compliance - StockTitan

Mar 18, 2025

Jaguar Health Inc Stock (JAGX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$60.29
price down icon 0.48%
$68.09
price down icon 1.58%
$17.32
price down icon 0.23%
$31.03
price down icon 0.26%
$86.82
price down icon 1.40%
biotechnology ONC
$220.54
price down icon 7.53%
Cap:     |  Volume (24h):